Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape - Alkermes (NASDAQ:ALKS)

Vanda Pharmaceuticals, Inc. VNDA was a big mover last session, as the company saw its shares rise by roughly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 30% in the past one-month time frame.

This biopharma company has no estimate revision over the last 30 days while its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Vanda Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Alkermes plc ALKS, Alexion Pharmaceuticals, Inc. ALXN and Gilead Sciences Inc. GILD. All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALKERMES INC ALKS: Free Stock Analysis Report

ALEXION PHARMA ALXN: Free Stock Analysis Report

GILEAD SCIENCES GILD: Free Stock Analysis Report

VANDA PHARMACT VNDA: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs